Recaticimab injection every 1-3 months may safely lower bad cholesterol

A new PCSK9 inhibitor (recaticimab) injected every one to three months may work safely and provide more flexible dosing to lower cholesterol, according to late-breaking science presented today at the American Heart Association’s Scientific Sessions 2023.

CDC recommendations for pneumococcal vaccine in adults

Updated recommendations from the CDC on the use of pneumococcal vaccines in adults in the United States.

September 12, 2023

Ovid asks USPTO to review Marinus’ patent around treatment of serious seizure condition

Ovid Therapeutics is ramping up its patent fight with Marinus Pharmaceuticals. The rival biotechs have been battling for more than a year over patent claims

March 28, 2024

Seres Therapeutics sheds about 160 jobs to focus on commercial C. diff pill

Seres Therapeutics will end most R&D work to focus resources on its commercial product in a move that will result in letting go about 160

November 3, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.